Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | The future of AI in guiding radiotherapy treatment for breast cancer

Philip Poortmans • 13 Mar 2025
BCC 2025
Breast Cancer

Philip Poortmans, MD, PhD, University of Antwerp, Antwerp, Belgium, describes the potential of artificial intelligence (AI) guide more tailored radiotherapy decisions in breast cancer. Following on Lucerne Toolbox 2, which aims optimize axillary management, Toolbox 3 will attempt to incorporate AI to enhance prognostic and predictive outcomes, enabling better patient selection and personalized treatment planning. AI can also aid in defining precise target volumes and optimizing dose distribution, ultimately improving treatment efficacy. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Philip Poortmans

How can AI tailor radiotherapy decision-making in breast cancer?
1:10
How can AI tailor radiotherapy decision-making in breast cancer?
Philip Poortmans • 13 Mar 2025
ULTIMO: cosmetic outcomes of UHF versus CF radiotherapy in breast cancer
1:38
ULTIMO: cosmetic outcomes of UHF versus CF radiotherapy in breast cancer
Philip Poortmans • 13 Mar 2025
Rationale behind tailoring radiation therapy in the pCR setting
2:46
Rationale behind tailoring radiation therapy in the pCR setting
Philip Poortmans • 16 May 2024
Controversies and uncertainties in axillary management
2:41
Controversies and uncertainties in axillary management
Philip Poortmans • 16 Mar 2023

Related Videos

Radiation response as a biomarker for adjuvant breast cancer therapy
1:56
Radiation response as a biomarker for adjuvant breast cancer therapy
Corey Speers • 1 Jun 2026
Expanding the clinical use of multimodal AI in breast cancer care
1:38
Expanding the clinical use of multimodal AI in breast cancer care
Corey Speers • 1 Jun 2026
MMAI model validation for chemotherapy benefit prediction in breast cancer
1:58
MMAI model validation for chemotherapy benefit prediction in breast cancer
Corey Speers • 1 Jun 2026
GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: a real-world analysis
1:33
GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: a real-world analysis
Zunairah Shah • 30 May 2026
The content of VJOncology is intended for healthcare professionals